|

Autologous tumor infiltrating lymphocyte injection（GT201） Clinical Trials

2 actively recruiting trials

Pipeline

Early 1: 1

Top Sponsors

  • Grit Biotechnology2

Indications

  • Cancer2
  • Adult Gynecological Tumors1
  • Gynecological Tumors1
  • Adult1

Other2 trials

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors
Early 1
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (advanced Cervical Cancer)
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.